We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
IntelliPharmaCeutics International Inc (QB) | USOTC:IPCIF | OTCMarkets | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 0.06 | 0.06 | 0.12 | 0.00 | 14:30:01 |
Title of Each Class of Securities To Be Registered
|
Proposed Maximum Aggregate Offering Price (1) (2) (3)
|
Amount of Registration Fee (2)
|
Units, each Unit
consisting of one common share, no par value (
“
Common Shares
”
), and one warrant (
“
Warrant
”
) to purchase one Common Share
(3)
|
$
1,200,000
|
$
145.44
|
(i) Common Shares
included in the Units (4)
|
—
|
—
|
(ii) Warrants
included in the Units (4)
|
—
|
—
|
Pre-Funded Units,
each Pre-Funded Unit consisting of one pre-funded warrant
(
“
Pre-Funded
Warrant
”
) to purchase one
Common Share and one Warrant to purchase one Common Share
(3)
|
$
1,188,000
|
$
143.99
|
(i) Pre-Funded
Warrants included in the Pre-Funded Units (4)
|
—
|
—
|
(ii) Warrants
included in the Pre-Funded Units (4)
|
—
|
—
|
Common Shares
issuable upon exercise of warrants (3)
|
$
1,200,000
|
$
145.44
|
Common Shares
issuable upon exercise of pre-funded warrants (3)
|
$
12,000
|
$
1.45
|
Underwriter
’
s
Warrants (5)
|
|
|
Common Shares
issuable upon exercise of Underwriter
’
s Warrants (6)
|
$
90,000
|
$
10.91
|
Total
|
$
3,690,000
|
$
447.23
|
Exhibit Number
|
Description
|
|
|
|
|
|
|
INTELLIPHARMACEUTICS INTERNATIONAL INC.
|
||
|
|
|
|
|
By:
|
/s/ Dr. Amina
Odidi
|
|
|
|
Dr.
Amina Odidi
|
|
|
|
President,
Chief Operating Officer and Director
|
|
Signature
|
|
Title
|
|
Date
|
|
|
|
|
|
/s/ Dr. Isa
Odidi
|
|
Chairman
of the Board of Directors
|
|
October
12, 2018
|
Dr. Isa
Odidi
|
|
Chief
Executive Officer and Co-Chief Scientific Officer (Principal
Executive Officer)
|
|
|
|
|
|
|
|
/s/ Andrew
Patient
|
|
Chief
Financial Officer
|
|
October
12, 2018
|
Andrew
Patient
|
|
(Principal Financial
and
Accounting Officer)
|
|
|
|
|
|
|
|
/s/ Dr. Amina
Odidi
|
|
President,
Chief Operating Officer, Co-Chief Scientific Officer and
Director
|
|
October
12, 2018
|
Dr.
Amina Odidi
|
|
|
|
|
|
|
|
|
|
|
|
Director
|
|
|
Kenneth
Keirstead
|
|
|
|
|
|
|
|
|
|
/s/ Bahadur
Madhani
|
|
Director
|
|
October
12, 2018
|
Bahadur
Madhani
|
|
|
|
|
|
|
|
|
|
|
|
Director
|
|
|
Eldon
R. Smith
|
|
|
|
|
|
|
|
|
|
/s/ Shawn
Graham
|
|
Director
|
|
October
12, 2018
|
Shawn
Graham
|
|
|
|
|
|
VASOGEN INC.
|
||
|
|
||
|
By
:
|
/s/ Dr. Amina
Odidi
|
|
|
|
Name:
Dr. Amina Odidi
|
|
|
|
Title:
President, Chief Operating Officer, Co-Chief Scientific Officer and
Director
|
1 Year IntelliPharmaCeutics (QB) Chart |
1 Month IntelliPharmaCeutics (QB) Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions